EXEL Exelixis, Inc.

HealthcareBiotechnology
$46.21
5.11%
53
QScore Signal
Hold
Confidence: MEDIUM
Long-Term
53
Short-Term
54

Value

57
P/E14.32
69
P/B6.17
44
P/S4.94
47
EV/EBITDA11.78
65

Growth

47
Revenue Growth7.0%
46
EPS Growth60.0%
47
FCF Growth33.2%
48

Momentum

67
12-Month Return25.4%
66
3-Month Return9.1%
74
1-Month Return4.5%
62
RSI (14)54.19
58
50/200 MABullish
75

Profitability

72
ROE40.2%
59
ROA32.1%
100
Gross Margin71.6%
60
Operating Margin39.4%
76
Net Margin35.1%
80
FCF Yield7.8%
65

Risk

27
Beta0.39
35
60-Day Volatility37.1%
20

Generated 5/7/2026, 10:01:12 PM · How is this calculated?

QScore Analysis